Form 8-K - Current report:
SEC Accession No. 0000950170-24-107776
Filing Date
2024-09-18
Accepted
2024-09-18 16:07:37
Documents
25
Period of Report
2024-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20240916.htm   iXBRL 8-K 61575
2 EX-4.1 apvo-ex4_1.htm EX-4.1 201602
3 EX-4.2 apvo-ex4_2.htm EX-4.2 160155
4 EX-10.1 apvo-ex10_1.htm EX-10.1 164843
5 EX-10.2 apvo-ex10_2.htm EX-10.2 328932
6 EX-10.3 apvo-ex10_3.htm EX-10.3 199235
7 EX-10.4 apvo-ex10_4.htm EX-10.4 212288
8 EX-10.5 apvo-ex10_5.htm EX-10.5 198476
9 EX-10.6 apvo-ex10_6.htm EX-10.6 214894
10 EX-10.7 apvo-ex10_7.htm EX-10.7 189869
11 EX-10.8 apvo-ex10_8.htm EX-10.8 185777
12 EX-99.1 apvo-ex99_1.htm EX-99.1 16750
13 EX-99.2 apvo-ex99_2.htm EX-99.2 15939
14 GRAPHIC img237228349_0.jpg GRAPHIC 4584
15 GRAPHIC img238151870_0.jpg GRAPHIC 4584
  Complete submission text file 0000950170-24-107776.txt   2629934

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20240916.xsd EX-101.SCH 26036
27 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20240916_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 241307524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)